Addiction, Author Interviews, Mental Health Research / 31.03.2025

Parita K. Ray

Medical Student

Department of Medical Education

Geisinger College of Health Sciences

Scranton, PA 18509

 

MedicalResearch.com: What is the background for this study?

  • Citalopram and escitalopram are two of the most commonly prescribed antidepressants in the U.S. and are widely used for treating major depressive disorder (MDD) and generalized anxiety disorder (GAD), along with various off-label indications. While both medications share similar mechanisms of action, escitalopram was introduced as a purified version of citalopram’s active enantiomer. Despite little evidence showing a clear superiority of escitalopram over citalopram in efficacy or tolerability, prescribing trends appear to favor escitalopram, raising concerns about "evergreening"—a practice where pharmaceutical companies promote newer formulations of existing drugs to extend market exclusivity. Prior research has shown variations in the prescription rates of psychotropic medications across states and within specific populations, particularly among Medicaid and Medicare patients. However, little is known about the long-term prescribing patterns of citalopram versus escitalopram in these populations and whether these trends reflect potential evergreening practices.

(more…)

Addiction, addiction-treatment, Author Interviews / 28.03.2025

When you’re struggling with addiction, finding the right treatment can feel like navigating through a dense fog. You’ve probably tried different approaches, maybe battled with outpatient programs, but still find yourself searching for a comprehensive solution. This is where a rehab becomes your beacon of hope. While outpatient programs offer flexibility, inpatient rehab provides a structured, immersive environment that significantly enhances the chances of long-term recovery. 

A Distraction-Free Healing Environment

One of the biggest advantages of inpatient rehab in Los Angeles is the opportunity to step away from the triggers and stressors of daily life. At home, temptations, unhealthy relationships, or stressful work conditions can make recovery more challenging. In a dedicated rehab facility, you can fully focus on your healing without distractions.  (more…)
Author Interviews, Cannabis, Pediatrics / 26.03.2025

MedicalResearch.com Interview with: Mr. Abay Tadesse,  PhD candidate School of Population Health Curtin University Australia MedicalResearch.com: What is the background for this study? Response: Few studies have investigated the association between maternal gestational cannabis use and the risk of disruptive behavioural disorders (DBDs) in offspring. Small sample sizes, reliance on self-reported data and focus on solely in-utero exposure often limit existing research, leading to inconsistent findings. Given the increasing prevalence of cannabis use during pregnancy, there is an urgent need for robust, population-based evidence to better understand its potential impact on child neurobehavioral outcomes. This study aimed to examine the relationship between maternal cannabis use disorder (CUD) during pregnancy and postpartum periods and the risk of DBDs in offspring. Using linked health data from New South Wales, Australia, we conducted a population-based retrospective cohort study of live births between 2003 and 2005. (more…)
Author Interviews / 26.03.2025

Motorcycles offer freedom on the open road, but riders face significant risks due to minimal protection. Motorcycle crashes frequently lead to lasting physical and financial consequences. Understanding these risks helps riders stay prepared and take the necessary precautions. Baton Rouge, Louisiana, has a population of over 220,000. Known for its rich culture, good economy, and deep historical roots, it thrives in the petrochemicals, healthcare, and education industries. As a central hub, the city sees heavy traffic, increasing the chances of motorcycle-related collisions. When an accident occurs, seeking legal assistance becomes crucial. Motorcycle accident lawyers in Baton Rouge support injured riders, ensuring they receive the compensation they deserve. This article examines the most common injuries a motorcycle accident victim is vulnerable to and why they require immediate attention. (more…)
Author Interviews / 24.03.2025

advancements_in_the_prosthetic_market   Prosthetics have been around for years and they are very helpful to those that need them. It gives people a sense of hope having a prosthetic leg which allows them to walk normally. There are other forms of prosthetics but limbs seem are the most common. Over the years the advancements of prosthetic and orthotic solutions have been very monumental. Some prosthetics actually look like an arm instead of those that look like a hook or claw. Primecare Prosthetics is one of those companies that is making advancements in prosthetics. Prosthetics look better and cleaner today  A lot of prosthetics today look a lot better. There’s nothing wrong with how they looked back then, but nowadays, prosthetics can look a bit more realistic. It’s still made of the basic elements like polyethylene, plastic, and metals. But they can look like many shade of skin color so it matches your skin tone. There are still those that look mechanical and some people prefer them. The advancements is that they look cleaner and more polished. They look a bit more robotic and they are presentable. They’re not messy and are also easy to clean. (more…)
Author Interviews, Psychological Science / 22.03.2025

MedicalResearch.com Interview with: Will Wei Wu, PhD student Leeds School of Business University of Colorado Boulder MedicalResearch.com: What is the background for this study? Response:  Imagine watching the latest episode of Succession while texting friends about the dramatic plot twists and checking social media for others’ reactions. Second screen behaviors like this have become ubiquitous, with 83% of Americans using additional devices—like smartphones or tablets—while watching television. Traditionally, second screening has been thought to diminish the viewing experience by dividing attention. However, our research challenges this view, suggesting that second screen use can actually enhance media consumption when used appropriately. Our study investigates how second screen use (using smartphones or tablets while watching media) influences viewers’ feelings of social connection and likelihood of repeat viewing. (more…)
Author Interviews, Weight Research / 20.03.2025

MedicalResearch.com Interview with: Prof. Marwan EL GHOCH Professore Associato in Scienza dell'Alimentazione e Tecniche Dietetiche Applicate MEDS-08/C Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze Università di Modena e Reggio Emilia Modena, 41125, Italy MedicalResearch.com: What is the background for this study? Response: Body mass index (BMI) is an easy-to-use tool to determine an individual’s by classifying him/her as having normal weight, overweight, or obesity, and this is based on universal cut-off points suggested by the World Health Organization (WHO) for all age groups. Not taking into account the potential changes that may occur to body composition compartments during the individual’s lifespan. In fact, little is still known about this topic in people with overweight and obesity. For this reason our study aimed to compare the body composition compartments between three different age groups (young, middle-age, and older adults), adopting a design that matched these 3 age groups by BMI. (more…)
Author Interviews / 20.03.2025

Editor’ note:  Cannabis and THCA/HEMP CBD products should have an active ingredient list on the container and have a Certificate of Analysis (COA). Discuss your use of CBD products with your health care provider.  Dosing of CBD is variable, especially since it is not FDA regulated. CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery.  Children should not be exposed to cannabis or CBD products. In recent years, medical marijuana has been widely applied across the USA. However, in some states its use is still a bit restricted, like in North Carolina. As scientists and medical specialists continue to explore the therapeutic power of marijuana, the list of cases when it is allowed to be used expands year after year. If we speak about North Carolina in particular, patients who suffer from specific health states can legally obtain medical cannabis from licensed medical marijuana doctors only. This treatment is very effective in general. (more…)
Author Interviews, Infections / 12.03.2025

  human-pathogens.jpg   Have you ever pondered how invisible microbes can trigger illnesses around us? Did you know millions fall ill, even fatally, due to human pathogens each year? These unseen threats are ever - present, silently invading our bodies and causing diseases ranging from mild colds to severe ones like AIDS and tuberculosis. Accurate detection of these pathogens is crucial for our health protection.

What are Human Pathogens?

Human pathogens are disease - causing microbes and parasites. An infection occurs when pathogens invade tissues, multiply, and trigger a reaction from the host's tissues to the pathogens and their toxins. Mammalian hosts initially respond to infections with an innate response, often involving inflammation, followed by an adaptive response. These organisms colonize host tissues, prompting the host immune system to produce specific antibodies against them. (more…)
Author Interviews, Critical Care - Intensive Care - ICUs, Genetic Research, Pediatrics / 10.03.2025

MedicalResearch.com Interview with: Ricki S. Carroll, MD Complex Care and Palliative Care Physician, Skeletal Dysplasia and Palliative Care Teams Nemours Children’s Hospital Wilmington, Delaware MedicalResearch.com: What is the background for this study? Response: Individuals with Osteogenesis imperfecta (OI) are often classified into one of four subtypes: type I (mild/nondeforming), type II (perinatal lethal), type III (severe/progressively deforming) and type IV (moderately deforming); however, this classification system continues to evolve with increasing knowledge (Sillence, 1979; Van Dyke & Sillence, 2014). Those with a mild phenotype are often diagnosed postnatally or in the pediatric setting after experiencing multiple unexplained fractures. Concerns for moderate to severely presenting OI are often noted in utero when fractures, shortening, and/or bowing of the long bones are found on prenatal ultrasound (Marini et al, 2017). When Osteogenesis imperfecta is suspected and/or molecularly confirmed in the prenatal period, families may be counseled that the diagnosis is lethal or severely life-limiting based on prenatal ultrasound observations and previously reported genotype-phenotype correlations (Yoshimura et al., 1996; Krakow et al., 2009). Ultrasound parameters for predicting lethality in skeletal dysplasias have been studied and include the chest-to-abdominal circumference ratio of <0.6 and femur length-to-abdominal circumference ratio of <0.16 (Yoshimura et al., 1996; Rahemtullah et al., 1997; Ramus et al., 1998). However, there are nuances to this strategy, for instance in cases where bowing deformities and fractures limit the accuracy of true femur length measurements (Milks et al., 2017). While genotype-phenotype correlations are also considered when predicting lethality, there can be a range of clinical variability even among those with the same genotype (Rauch et al., 2004, Marini et al, 2017). Some specialized delivery centers have reported on the accuracy of these methods in predicting lethality, yet many of the pregnancies evaluated are ultimately terminated, further limiting the ability to draw conclusions (Yeh et al., 2011). These limitations pose a challenge for perinatal providers counseling families on the diagnosis and attempting to prognosticate postnatal survival probability. Consequently, this information can cloud conversations surrounding delivery planning and influence access to potential life-saving therapies including invasive mechanical ventilation and feeding support. Advancements in medical technology and the option for life-sustaining interventions have significantly altered the prognoses for severely affected infants. In this manuscript, we describe perinatal outcomes of infants referred to a single specialized center after receiving a prior diagnosis of possibly lethal, lethal or type II OI where parents sought medical intervention after birth. We also outline advances in respiratory and feeding support needs, as well as length-of-stay for these neonates. The success of this multidisciplinary approach to neonatal OI care both challenges previously defined expectations for this patient population and offers a chance at survival. (more…)
Author Interviews, Infections, NEJM, STD / 06.03.2025

MedicalResearch.com Interview with: Lenka Vodstrcil PhD Senior Research Fellow Deputy Head, Genital Microbiota and Mycoplasma Group President, Sexual Health Society of Victoria Associate Editor, Sexually Transmitted Infections School of Translational Medicine, FMNHS, Monash University Melbourne Sexual Health Centre, The Alfred Hospital Melbourne School of Population & Global Health, University of Melbourne Catriona Bradshaw MMBS(Hons), PhD, FAChSHM, FAHMS Professor (Research), Head of Research Translation and Mentorship and of The Genital Microbiota and Mycoplasma Group Melbourne School of Translational Medicine, Monash University and Alfred Hospital Principal Research Fellow at the Burnet Institute   MedicalResearch.com: What is the background for this study? Response: One in three women globally have bacterial vaginosis (BV), a condition that causes a malodourous discharge, and associated with serious gynaecologic and obstetric sequelae (including miscarriage and preterm birth) and increases the risk sexually transmitted infections (STIs) and HIV. Women with symptoms are treated with broad-spectrum antibiotics, however, over 50% of women experience BV recurrence within 3-6 months. The recurrence rate is even higher at 60-80% among women with an ongoing regular partner. Current practice is to simply retreat women experiencing BV recurrence with the same antibiotics, which leaves them (and clinicians) frustrated and distressed. We and others have accumulated a body of evidence to show that BV has the profile of an STI. BV-associated bacteria are detected in men in the distal urethra and on penile-skin, and couples share these organisms. However, to date, has not been recommended for BV as it is for other STIs. This is largely because men do not usually have any symptoms, and past partner-treatment trials in the 1980s and 1990s, which only used oral antibiotics for men, failed to prevent BV recurrence, which was taken as conclusive evidence against sexual transmission. Reviews of these trials have since identified their limitations. Given the evidence of male carriage of BV-associated bacteria at two genital sites, we hypothesised that both sites needed to be targeted with antimicrobial therapy to prevent re-infection post-treatment. The aim of our study was to assess if male partner-treatment concurrently with female treatment using a combination of oral and topical antibiotics for the first time, would decrease BV recurrence over 12 weeks compared to the current standard practice of treating women only. (more…)
Author Interviews, Cannabis / 27.02.2025

MedicalResearch.com Interview with: Elena Stains Medical Student Department of Medical Education Geisinger Commonwealth School of Medicine Scranton, PA MedicalResearch.com: What is the background for this study? Response: In 2019 to 2020, 2.5% of Americans reported using cannabis for medical needs, compared to 1.2% in 2013-2014, representing a 12.9% annual increase1. Forty states and the District of Columbia have legislation for some form of medical cannabis (MC) in 2024. Because MC is not federally legalized, each state creates its own legislation on the conditions that qualify a person for MC, without any standardized process to determine what qualifying conditions (QC) are proven to be aided by MC. Thus, the QCs chosen by states vary widely. Common QCs include cancer, dementia, and PTSD. The National Academies of Sciences, Engineering, and Medicine (NAS) published a report in 2017 on the evidence for the therapeutic effects of cannabis and cannabinoids for over twenty conditions2. This report reviews the evidence of effectiveness of medical cannabis for the most common QCs chosen by states. The researchers at Geisinger Commonwealth School of Medicine aimed to compare the evidence found by the NAS report with the QCs of 38 states (including the District of Columbia) in both 2017 and 2024. QCs were categorized based on NAS-established level of evidence: limited, moderate, or substantial/conclusive evidence of effectiveness, limited evidence of ineffectiveness, or no/insufficient evidence to support or refute effectiveness (Table 1). (more…)
Author Interviews, Genetic Research, Lancet, Ophthalmology / 26.02.2025

MedicalResearch.com Interview with: Professor Michel Michaelides BSc MB BS MD(Res) FRCOphth FACS Professor of Ophthalmology and Consultant Ophthalmic Surgeon UCL Institute of Ophthalmology and Moorfields Eye Hospital     MedicalResearch.com: What is the background for this study?
  • Leber congenital amaurosis (LCA) is a rare inherited retinal disease (IRD) that causes the degeneration of the cone and rod cells in the retina. It is characterized by severe vision loss at birth/early infancy and is one of the commonest causes of legal blindness in childhood. There is a wide range of severity at birth/early infancy, ranging from light perception to useful central vision; with variable rate of progression over time, LCA is estimated to occur in about 1 in 33,000 people. There are more than 30 genes that cause LCA.
  • LCA associated with genetic deficiency of AIPL1 is one of the most severe forms of LCA – resulting in profound visual loss from birth (often light perception only) and rapidly progressive retinal degeneration.
  • The study sought to evaluate whether early intervention by gene supplementation therapy in children with LCA associated with AIPL1 was safe and could improve outcomes.
(more…)
Antibiotic Resistance, Author Interviews, Infections / 18.02.2025

MedicalResearch.com Interview with: Jennifer Machado Soares Affiliation: University of São Paulo and Texas A&M University Institute of Physics of São Carlos, University of São Paulo, São Carlos, SP, Brazil. MedicalResearch.com: What is the background for this study? Response: Antibiotic treatments are becoming less effective due to the increasing prevalence of multidrug-resistant bacteria. Alternative treatments such as Antimicrobial photodynamic therapy (aPDT) have emerged and can act as an adjuvant to traditional antibiotic therapy. aPDT utilizes a photosensitizer activated by light to generate reactive oxygen species that can inactivate pathogens. (more…)
Author Interviews, Cancer Research, Colon Cancer, Stem Cells / 14.02.2025

MedicalResearch.com Interview with: Slim Mzoughi, PhD Assistant Professor Icahn School of Medicine at Mount Sinai Department of Oncological Sciences Hess Center for Science and Medicine New York, NY 10029 MedicalResearch.com: What is the background for this study? Response: Resistance to current cancer treatments remains one of the biggest challenges in oncology, often leading to cancer recurrence even after patients appear to be in remission. To overcome this obstacle, we first need to understand the mechanisms behind this resistance. For a long time, treatment resistance in colorectal cancer (CRC)—the second deadliest cancer worldwide—has been attributed to a specific group of cells known as LGR5+ cancer stem cells. However, recent studies suggest that simply targeting these cells is insufficient for achieving long-term cancer control. That’s where our study comes in—to uncover why this is the case. MedicalResearch.com:  What are the main findings? Response:  Our study reveals that, early in tumor formation, LGR5+ cancer stem cells undergo molecular changes that render them unrecognizable. These changes cause them to resemble those found in the developing fetal intestine. In a way, this transformation reminds me of the legend of Edward Mordake, where these now fetal-like cells act as the “demon face” of cancer stem cells, resisting and surviving treatment. Crucially, we have identified the mechanism driving this reversion to a fetal-like state, which we term oncofetal-reprogramming. Excitingly, when we targeted the oncofetal cell state alongside existing chemotherapy treatments, this significantly enhanced treatment effectiveness and extended survival in preclinical models, offering new hope for CRC patients. (more…)
Author Interviews, Gender Differences, JAMA, University of Michigan / 14.02.2025

MedicalResearch.com Interview with: Farrah Madanay, PhD Postdoctoral Research Fellow Center for Bioethics and Social Sciences in Medicine Michigan Medicine University of Michigan MedicalResearch.com: What is the background for this study? Response: Patients are increasingly using online forums to evaluate their physicians, with not only star ratings but also written narrative reviews. These reviews tend to fall into two dimensions: interpersonal manner, which includes comments about the physician’s attitude, behavior, and communication; and technical competence, which includes comments about the physician’s knowledge, skill, and outcomes. These two dimensions are important for patient-centered care and align with research from social psychology. Whereas prior studies have revealed gender differences in workplace assessments and overall star ratings of physicians, little is known about physician gender differences in patients’ online written reviews. We were curious whether physician gender differences were prevalent in patients’ written reviews and consistent across physician specialties, from generalists, like primary care physicians, to proceduralists, like surgeons. We collected physician profile, rating, and review data from one of the largest commercial physician rating and review websites. We focused on physicians from three primary care specialties (family medicine, internal medicine, and pediatrics), and three surgical specialties (general surgery; orthopedic surgery; and cosmetic, plastic, and reconstructive surgery). Our final sample included 345,053 online reviews received by 167,150 U.S. physicians between 2015 and 2020. We used hand-coded reviews to train an advanced natural language processing algorithm to classify all reviews for the presence and valence of patients’ comments of physicians’ interpersonal manner and technical competence. We then conducted multilevel logistic regressions to analyze differences by female or male physician gender in interpersonal manner and technical competence comments and whether those comments were associated with review star ratings. (more…)
Author Interviews, Autism, Pediatrics / 14.02.2025

MedicalResearch.com Interview with: Magdalena Janecka PhD Associate Professor, Department of Child and Adolescent Psychiatry Associate Professor, Department of Population Health NYU Grossman School of Medicine MedicalResearch.com: What is the background for this study? Response: Several earlier studies have indicated that certain maternal conditions in pregnancy – for example, depression or obesity - are associated with higher rates of autism in offspring. However, the majority of the conditions females experience during pregnancy have not been investigated in the context of autism before. Additionally, while the evidence that these associations are likely not causal existed for a few maternal diagnoses, it was not clear whether this applies to just a few associations that have been examined or is more widespread. Our study investigated the association between all maternal conditions in pregnancy (provided they were common enough to allow us to estimate their effects) and the likelihood of autism in the child. Then, for the significant associations, we tested whether these associations seemed causal, or whether they were instead attributable to other confounding factors. Confounders are other variables that can influence the relationship between the variables in a study, for example maternal health and autism. Factors shared by family members, i.e. familial factors (e.g., genetics) are common confounders in studies like ours, and are particularly difficult to account for. (more…)
Allergies, Author Interviews, NEJM, Pediatrics / 11.02.2025

Editor's note:  Do not attempt immunotherapy for peanut or other allergens without the express direction of your health care provider. Life-threatening reactions may occur. MedicalResearch.com Interview with: Scott H. Sicherer, MD Elliot and Roslyn Jaffe Professor of Pediatrics, Allergy and Immunology Director, Jaffe Food Allergy Institute Division Chief, Pediatric Allergy Medical Director, Clinical Research Unit Icahn School of Medicine at Mount Sinai Jack and Lucy Clark Department of Pediatrics Mount Sinai Kravis Children’s Hospital New York, NY 10029 MedicalResearch.com: What is the background for this study? Response: About 2% of people have a peanut allergy.  While many of them are exquisitely allergic to tiny amounts, about half can tolerate a half a peanut kernel or more before they have symptoms, although the symptoms can be severe. Current studies and FDA approved treatments for peanut allergy have typically focused on people reacting to about half a peanut or less.  We thought that those with higher threshold may be more easily treated. We focused on children ages 4-14 years who we identified through a medically supervised feeding test as having allergic reactions from 443 to 5043 mg of peanut protein.  A peanut kernel is about 250 mg of peanut protein. The 73 children were randomized to a treatment (oral immunotherapy, OIT) using home-measured, store bought peanut butter versus continuing the standard of care, avoidance.  OIT involves medically supervised dosing going from a small amount to gradually increasing larger amounts.  The increases are done under direct allergist supervision, then the tolerated dose is taken at home daily. Families are given instructions about avoiding things that can cause a reaction from dosing, such as exercise after a dose, and to skip dosing for illness.  Dosing can cause reactions and they were instructed on how to recognize and treat any such reactions.   We did increases every 2 months. Most of the children (62) stayed in the study to be tested after the period of treatment, that aimed for having a level tablespoon of peanut butter each day. All of the treated children who completed testing (32) were able to eat 9 grams of peanut.  Only 3 of 30 who continued to avoid peanut were able to do this. (more…)
Author Interviews, Gastrointestinal Disease / 11.02.2025

MedicalResearch.com Interview with: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Medicine Weill Cornell Medical Center Transplant hepatologist at NewYork-Presbyterian/Weill Cornell Medical Center MedicalResearch.com: What is the background for this study? Response: In recent years, the demand for gastroenterologists continues to increase due to an aging population, increase in the prevalence of gastrointestinal and hepatology diseases, updates in screening and surveillance recommendations, and advances in therapeutic techniques. In this study, we set out to examine geographic distributions of gastroenterologists in the United States. MedicalResearch.com: What are the main findings? Response:  We found that on a national level, over 80% of the population lives within 25 miles of the closest gastroenterologist. However, 2,183 (69%) of the US counties do not have a practicing gastroenterologist, and 454 of the 1,167 metropolitan counties in the US do not have a gastroenterologist. Additionally, gastroenterologists in non-metropolitan counties tend to be older, with almost a third over the age of 65. (more…)
Author Interviews, Mental Health Research, Microbiome / 10.02.2025

MedicalResearch.com Interview with: Associate Professor Shawn Je Neuroscience and Behavioural Disorders Programme, Duke-NUS Medical School MedicalResearch.com: What is the background for this study? What questions were you trying to address?  Response: The project started in 2013 when I met Professor Sven Petterson, then a visiting professor from the Karolinska Institute, during his time at the National Cancer Centre Singapore (NCCS) in Singapore. At the time, our lab was studying autism, and we discovered that many children with autism also had gastrointestinal problems. This sparked my interest in the relationship between gut microbiota and brain disorders. Professor Petterson had already established a germ-free facility at NCCS to study the link between cancer and gut microbiota. I asked him if he could create germ-free C57BL/6 mice, a strain often used to study learning, memory and brain disorders. After developing the mice, we subjected them to behavioural testing at the Duke-NUS Behavioural Phenotyping Facility to assess their emotional responses (fear, anxiety, depression), cognitive abilities (learning and memory), and social interactions. We were surprised to find that the germ-free C57BL/6 mice exhibited increased anxiety, although no significant changes in social behaviours typical of autism were observed. Anxiety was assessed using tests in which mice were placed in an elevated arena with open and closed sections, and the time spent in each area was measured. The increased anxiety in these germ-free mice had not been reported before, so we repeated the tests several times to confirm the findings. Interestingly, other researchers had observed hyperactivity in germ-free mice of different strains, but our C57BL/6 mice showed unusual anxious behaviour, even though this strain typically has lower anxiety. This led us to investigate the underlying mechanisms behind the increased anxiety in these mice, with the goal of discovering why this particular strain exhibited such pronounced anxiety. (more…)
Author Interviews, JAMA, Salt-Sodium, Stroke / 09.02.2025

MedicalResearch.com Interview with: Xiong Ding, MPH School of Public Health Wuhan University Wuhan, China MedicalResearch.com: What is the background for this study? Response: Stroke is one of the leading causes of death and long-term disability worldwide, particularly in low- and middle-income countries. Patients who have previously experienced a stroke are at high risk of recurrence, and in China, this risk is even higher than the global average. It is well established that high blood pressure is a major risk factor for stroke recurrence, and lowering blood pressure is an effective preventive strategy. Salt substitutes, which replace part of sodium chloride with potassium chloride, have been shown to lower blood pressure by reducing sodium intake and increasing potassium intake. However, before our study, there was limited direct evidence demonstrating whether salt substitutes could reduce the risk of stroke recurrence and death. Therefore, we conducted this research as part of the Salt Substitute and Stroke Study (SSaSS), specifically focusing on stroke survivors to determine the long-term health effects of salt substitution in this high-risk population. (more…)
Author Interviews, Infections / 05.02.2025

MedicalResearch.com Interview with: Prof. Vishnu Chaturvedi, Ph.D., HCLD Department of Pathology, Microbiology and Immunology New York Medical College Department of Pathology, Westchester Medical Center Valhalla, New York, MedicalResearch.com: What is the background for this study? How does Candida auris differ from Candida albicans, ie in clinical presentation or treatment?    
  1. Candida aurisis a newly discovered yeast that is considered a global health threat by the CDC and WHO. The sudden emergence and rapid spread of this multidrug-resistant pathogen is being explained by several published hypotheses. These include global warming, salt water tolerance, or agriculture use of fungicides as plausible causes. In the US, the NY-NJ metropolitan area was the first to suffer from drug-resistant Candia auris clade I genotype. None of the earlier hypotheses could explain the appearance in NY-NJ. Here, we set out to answer two related questions: “why NY-NJ?” and “why clade I?”
  2. Candida albicansis a well-known commensal yeast that frequents human mucosal surfaces in the mouth, vagina, etc. In contrast, Candida auris is a newly discovered yeast that colonizes the skin of hospitalized patients and long-term care residents. A small subset of those colonized develop Candida auris bloodstream and deep tissue infections.
  3. Candida auris differs from  albicans in its ability to cause healthcare-associated infection outbreaks. Candida auris is also prone to rapid acquisition of the resistance of multiple antifungal drugs. Finally, C. auris bloodstream infections cause high mortality.
(more…)
Author Interviews, Heart Disease, OBGYNE / 05.02.2025

MedicalResearch.com Interview with: Cande V. Ananth PhD MPH Professor and Vice Chair for Academic Affairs Chief, Division of Epidemiology and Biostatistics Department of Obstetrics, Gynecology, and Reproductive Sciences Rutgers Robert Wood Johnson Medical School, NJ Editor-in-Chief, Paediatric and Perinatal Epidemiology   MedicalResearch.com: What is the background for this study? Response: The rate of twin pregnancies worldwide has risen in recent decades, driven by fertility treatments and older maternal ages. MedicalResearch.com: What are the main findings? Response: Compared to singleton pregnancies with normal blood pressure, people with twins with normal blood pressure were around twice as likely to be hospitalized with cardiovascular disease. For those with twins with high blood pressure during pregnancy, the risk was more than eight times higher.  (more…)
Author Interviews / 02.02.2025

The healthcare industry has seen significant change recently as more focus is on offering people more easily available and more effective medical treatments. Sometimes, a patient's capacity to get quick treatment is hampered because, in the past, medical attention required appointments that took a lot of time, long waiting times and frequent in-person visits. On the other hand, developments in healthcare solutions have streamlined the patient experience and guaranteed that people obtain high-quality medical treatment with the least disturbance.  Building medical care accessibility and convenience    Geography, mobility issues, or hectic schedules often make it difficult for patients to access medical treatments. Technology-driven healthcare solutions have significantly reduced these barriers by enabling remote consultations, online prescriptions, and timely treatments. Eliminating logistical challenges ensures that modern healthcare systems allow people to seek medical attention without disrupting their daily routines. This shift toward convenience particularly benefits patients with chronic conditions, who require ongoing care but may find frequent clinic or hospital visits challenging. Online providers such as Anytime Doctor are very important in ensuring patients get competent and timely treatment free from needless waits, optimising access to medical care. As digital healthcare develops, these developments will increase patient outcomes, improve accessibility, and redefine medical treatment. (more…)
Author Interviews, Cannabis, JAMA, Pediatrics, UCSD / 30.01.2025

MedicalResearch.com Interview with: John Bellettiere, PhD Assistant Adjunct Professor Herbert Wertheim School of Public Health & Human Longevity Science University of California, San Diego MedicalResearch.com: What is the background for this study? Response:  Smoking is the most common method of cannabis use and generates harmful emissions.  Cannabis is often smoked indoors, which exposes non-smokers, including children, to these emissions. Our research analyzed in-home cannabis smoking practices to determine if there is an association between this behavior and the detection of cannabis biomarkers in children. (more…)
Author Interviews, Cannabis, Cognitive Issues, JAMA, Memory, Mental Health Research / 28.01.2025

MedicalResearch.com Interview with: Joshua Gowin PhD Assistant Professor, Radiology Anschutz Medical Campus University of Colorado  MedicalResearch.com: What is the background for this study? Response: Many people want to know how cannabis affects their brain and cognitive abilities. Previous studies have shown that cannabis use can impair learning and verbal memory function. Some evidence has shown that cannabis use is associated with smaller volume of areas of the prefrontal cortex. Our study investigated how cannabis use is associated with brain function. We examined brain function across 7 tasks in 1,000 adults. 88 of them had used cannabis over 1,000 times in their lives. (more…)
Author Interviews, Cancer Research / 28.01.2025

MedicalResearch.com Interview with: Christopher Choi, PhD, MBA Senior Vice President of Industry Partnerships Associate Professor of Oncology Technical Director of GMP Engineering & Cell Manufacturing Roswell Park Comprehensive Cancer Center Buffalo, NY MedicalResearch.com: What is the background for this study?  What is a GMP facility? Response: The opening of the Roswell Park GMP Engineering & Cell Manufacturing Facility (GEM) facility marks a significant milestone in advancing cell and gene therapy research at Roswell Park. Our GMP (Good Manufacturing Practice) facility is a specialized manufacturing space designed to produce cell-based and gene-based products under stringent regulatory conditions to ensure product safety, quality and consistency. These facilities are critical for translating innovative research into clinical-grade products that meet regulatory standards for use in patient care. The GEM Facility is part of our commitment to driving the next generation of cancer treatments and other advanced therapies, addressing a critical bottleneck in the development of these transformative technologies. (more…)
Author Interviews, Immunotherapy, Lymphoma / 27.01.2025

MedicalResearch.com Interview with: Joshua Brody MD Director, Lymphoma Immunotherapy Program Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, New York 10029   MedicalResearch.com: What is the background for this study?
  • Patients with relapsed diffuse large B-cell lymphoma (DLBCL) have poor outcomes.
  • Standard chemotherapy e.g. Gemcitabine + Oxaliplatin (GemOx) yields complete response in ~30% of these patients.
  • Epcoritamab, a CD3xCD20 bispecific antibody immunotherapy was recently approved for relapsed DLBCL as monotherapy but is not yet approved as part of combination therapy.
  • Other immunotherapies e.g. CAR-T have been difficult to combine with standard therapies.
(more…)
Author Interviews, Cannabis, JAMA / 25.01.2025

MedicalResearch.com Interview with: Silvia S. Martins, MD, PhD Associate Dean for Faculty Professor of Epidemiology Director, Substance Use Epidemiology Unit Co-Director, Substance Abuse Epidemiology T32 Program Department of Epidemiology Columbia University Mailman School of Public Health New York, NY MedicalResearch.com: What is the background for this study? Response: Much has been speculated on whether the enactment of medical and recreational cannabis laws can have a role in decreasing prescriptions for opioid pain relievers, opioid use and misuse, opioid use disorder, and overdose in the U.S. However, findings on the associations of medical cannabis laws alone and recreational cannabis las + medical cannabis laws with opioid-related outcomes are mixed. By the end of 2019, 32 U.S. states had adopted medical marijuana laws (MCL) alone. All states that went on to adopt recreational marijuana laws (RCL) had previously adopted an MCL. (more…)